Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant
Year: 2017
Type: article
Study design: Observational Study
Abstract: Infection, relapse, and GVHD can complicate allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although the effect of poor immune recovery on infection risk is well-established, there are limited data on the effect of immune reconstitution on relapse and survival, especially following T-cell depletion (TCD). To characterize the pattern of immune reconstitution in the first year after transplant and its effects on survival and relapse, we performed a retrospective study in 375 recipients of a myeloablative TCD allo-HSCT for hematologic malignancies. We noted that different subsets recover sequentially, CD8 + T cells first, followed by total CD4 + and naïve CD4 + T cells, indicating thymic recovery during the first year after HSCT. In the multivariate model, a fully HLA-matched donor and recovery of T-cell function, assessed by PHA response at 6 months, were the only factors independently associated with OS and EFS. In conclusion, T-cell recovery is an important predictor of outcome after TCD allo-HSCT.
Authors: Jenna D. Goldberg, Junting Zheng, Ravin Ratan, Trudy N. Small, Kuan-Chi Lai, Farid Boulad, Hugo Castro-Malaspina, Sergio A. Giralt, Ann A. Jakubowski, Nancy A. Kernan, Richard J. O’Reilly, Esperanza B. Papadopoulos, James W. Young, Marcel R.M. van den Brink, Glenn Heller, Miguel-Angel Perales
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2578541515
